Abstract
The growth and metastasis of solid tumors are dependent on the ability of tumor cells to induce angiogenesis [1]. Angiogenesis, the formation of new blood vessels from pre-existing ones, involves endothelial cell proliferation, motility, and tubular differentiation. It is known that tumor cells can secrete a variety of angiogenic factors, such as basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), to stimulate angiogenesis. Tumor cells also produce angiogenesis inhibitors such as thrombospondin and angiostatin to control angiogenesis. The balance between angiogenesis stimulators and inhibitors determines the angiogenicity of tumor cells [2]. Acquisition of the ability to stimulate angiogenesis by tumor cells is an integral part of tumorigenesis. Activated oncogenes, such as ras, or inactivated tumor suppressor genes, such as p53, not only increase mitogenesis and prevent apoptosis in tumor cells, but also lead to the development of an angiogenic phenotype [for review,.3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931–10934, 1992.
Hanahan D. and Folkman J. 1996. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353–364
Vartanian, R. K., and Weidner, N. EC proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason’s score, microvessel density, and epithelial cell proliferation. Lab. Invest., 73: 844–850, 1995.
Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., Asano, K., Tokuda, T., Aizawa, S., and Ushigome, S. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J. Pathol., 168: 257–262, 1992.
Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401–409, 1993.
Vukanovic, J., and Isaacs, J. T. Human prostatic cancer cells are sensitive to programed (apoptotic) death induced by the antiangiogenic agent linomide. Cancer Res., 55: 3517–3520, 1995.
Yamaoka, M., Yamamato, T., Ikeyama, S., Sudo, K., and Fujita, T. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res., 53: 5233–5236, 1993.
Campbell, S. C. Advances in angiogenesis research: relevance to urological oncology. J. Urol., 158: 1663–1674, 1997.
Gao, X., Grignon, DJ., Chbihi, T., Zacharek, A., Chen, Y.Q., Sakr, W., Porter, A.T., Crissman, J.D., Pontes, J.E., Powell, I.J., and Honn, K. V. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology 46: 227–237, 1995.
Funk, C. D., Furci, L., and FitzGerald, G. A. Molecular cloning, primary structure, and expression of the human platelet/erythroleukemia cell 12-lipoxygenase. Proc. Natl. Acad. Sci. USA 87:5638-5642, 1990.
Diglio, C. A., Liu, W., Grammas, P., Giacomelli, F., and Wiener, J. Isolation and characterization of cerebral resistance vessel endothelium in culture. Tissue and Cell 25: 833–846, 1993.
Hagmann, W., Gao, X., Timar, J., Chen, Y. Q., Strohmaier, A. R., Fahrenkopf, C., Kagawa, D., Lee, M., Zacharek, A., and Honn, K. V. 12-Lipoxygenase in A431 cells: genetic identity, modulation of expression, and intracellular localization. Exp. Cell Res., 228: 197–205, 1996.
Yamaoka, M., Yamamoto, T., Ikeyama, S., Sudo, K., Fujita, T. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Res., 53: 5233–5236, 1993.
Ito, Y., Iwamoto, Y., Tanaka, K., Okuyama, K., and Sugioka, Y. A quantitative assay using basement membrane extracts to study tumor angiogenesis in vivo. Int. J. Cancer 67:148–152, 1996.
Tang, D. G., Renaud, C., Stojakovic, S., Diglio, C. A., Porter, A., and Honn, K. V. 12(S)-HETE is a mitogenic factor for microvascular ECs: Its potential role in angiogenesis. Biochem. Biophys. Res. Commun., 211: 462–468, 1995.
Honn, K. V., Tang, D. G., Grossi, L, Duniec, Z. M., Timar, J., Renaud, C., Leithauser, M., Blair, I., Johnson, C. R., Diglio, C. A., Kimler, V. A., Taylor, J. D., and Marnett, L. J. Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. Cancer Res., 54: 565–574, 1994.
Tang, D. G., Chen, Y.Q., Diglio, C. A., and Honn, K. V. Transcriptional activation of EC integrin av by protein kinase C activator 12(S)-HETE. J. Cell Sci., 108: 2629–2644, 1995.
Brooks, P. G, Clark, R. A. F., and Cheresh, D. A. Requirement of vascular integrin αvβ3 for angiogenesis. Science 264: 569–571, 1994.
Brooks, P. C, Stromblad, S., Klemke, R., Visscher, D., Sarkar, F. H., and Cheresh, D. A. Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest, 96:1815–1822, 1995.
Kumar, R., Yoneda, J., Bucana, C. D., and Fidler, I. J. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int. J. Oncol., 12:749–757, 1998.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nie, D. et al. (1999). Platelet-Type 12-Lipoxygenase Regulates Angiogenesis in Human Prostate Carcinoma. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_90
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4793-8_90
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7171-7
Online ISBN: 978-1-4615-4793-8
eBook Packages: Springer Book Archive